Rut Meseguer Naturil | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Published on by Academic Excellence

Best Researcher Award

Rut Meseguer Naturil
Health Research Institute INCLIVA, Spain

Rut Meseguer
Affiliation Health Research Institute INCLIVA
Country Spain
Documents 2
Subject Area Biochemistry, Genetics and Molecular Biology
Event International Academic Excellence Awards
ORCID 0000-0003-4376-5997

Rut Meseguer Naturil is a researcher affiliated with the Health Research Institute INCLIVA in Spain whose documented research output includes work in immunology and translational biomedical science. The available publication record highlights research involving natural killer (NK) cell biology, immunotherapy manufacturing, and therapeutic strategies for severe infectious disease. These contributions provide a basis for consideration within the Best Researcher Award category of the International Academic Excellence Awards.

Abstract

The research record associated with Rut Meseguer Naturil encompasses biomedical investigation relevant to immune-cell biology and translational medicine. A recent publication examines how donor NKG2A/NKG2C immunophenotypes influence the GMP-compliant manufacturing potential of NK cells for adoptive immunotherapy, connecting donor characteristics with the practical development of cellular therapeutic products [1]. Earlier work addressed combined therapeutic approaches in severe-to-critical COVID-19, contributing to the broader understanding of treatment strategies for complex infectious disease [2].

Keywords

NK cells, natural killer cells, NKG2A, NKG2C, adoptive immunotherapy, GMP manufacturing, immunology, COVID-19, translational medicine, biochemistry, molecular biology.

Introduction

Natural killer cells are an important component of the human immune system and have attracted substantial interest as candidates for cellular immunotherapy. Their therapeutic development requires reproducible manufacturing processes and careful consideration of biological variability. Research examining donor immunophenotypes can therefore help clarify factors associated with NK-cell production and downstream therapeutic applications [1].

Research Profile

The documented research profile is situated within Biochemistry, Genetics and Molecular Biology and intersects with immunology and translational biomedical research. The available record identifies two documents, while citation and h-index information has not been supplied. The publications demonstrate engagement with clinically relevant questions involving immune-cell therapies and severe infectious disease.

Research Contributions

  • Investigated donor NKG2A/NKG2C immunophenotypes in relation to GMP-compliant NK-cell manufacturing for adoptive immunotherapy [1].
  • Contributed to research evaluating rationales for combined therapies in severe-to-critical COVID-19 patients [2].
  • Connected laboratory immunology with translational considerations relevant to cellular therapy and clinical treatment strategies.

Publications

Donor NKG2A/NKG2C Immunophenotype Influences the GMP-Compliant Manufacturing Potential of NK Cells for Adoptive Immunotherapy. Cancers, August 2026.[1].

Rationale for combined therapies in severe-to-critical COVID-19 patients. Frontiers in Immunology, September 11, 2023. [2].

Research Impact

The research addresses practical and clinically relevant questions in contemporary biomedical science. Work on GMP-compliant NK-cell manufacturing is particularly relevant to the translation of immune-cell research into standardized therapeutic products, while the COVID-19 publication contributes to the evidence base surrounding combination treatment strategies [1] [2].

Award Suitability

Rut Meseguer Naturil’s documented publications provide evidence of research activity spanning immune-cell biology, cellular therapy manufacturing, and clinical immunology. The combination of methodological and translational themes is relevant to the Best Researcher Award, particularly within the stated Biochemistry, Genetics and Molecular Biology subject area. Award assessment should consider the complete research record, including independently verifiable publications, scholarly impact, innovation, and broader contributions.

Conclusion

The available record presents Rut Meseguer Naturil as a researcher contributing to biomedical topics with relevance to immunotherapy and infectious disease. The documented studies provide a scholarly basis for recognition in the Best Researcher Award category, while further evaluation of the complete publication and impact record would provide a more comprehensive assessment.

References

  1. Meseguer Naturil, R., et al. (2026). Donor NKG2A/NKG2C Immunophenotype Influences the GMP-Compliant Manufacturing Potential of NK Cells for Adoptive Immunotherapy. Cancers, 18(17), 2732.
    https://doi.org/10.3390/cancers18172732
  2. Frontiers in Immunology. (2023). Rationale for combined therapies in severe-to-critical COVID-19 patients. Frontiers in Immunology. PMID: 37767093; PMCID: PMC10520558.
    https://doi.org/10.3389/fimmu.2023.1232472
  3. MDPI. (2026). Cancers, Volume 18, Issue 17, Article 2732. Multidisciplinary Digital Publishing Institute.
    https://www.mdpi.com/2072-6694/18/17/2732
  4. Europe PMC. (2023). Rationale for combined therapies in severe-to-critical COVID-19 patients. Europe PMC record, PMCID: PMC10520558.
    https://europepmc.org/article/pmc/PMC10520558
  5. ORCID. (n.d.). Rut Meseguer Naturil — ORCID record. ORCID iD: 0000-0003-4376-5997.
    https://orcid.org/0000-0003-4376-5997
  6. International Academic Excellence Awards. (n.d.). Academic Excellence Awards. Award program website.
    https://academicexcellenceawards.com/

Ramesa Shafi | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Published on by Academic Excellence

Best Researcher Award

Ramesa Shafi
King Saud University, Saudi Arabia

Ramesa Shafi
Affiliation King Saud University
Country Saudi Arabia
Scopus ID 57442927600
Documents 105
Citations 1,901
h-index 25
Subject Area Biochemistry, Genetics and Molecular Biology
Event International Academic Excellence Awards
ORCID 0000-0003-2149-6239

Ramesa Shafi is a researcher affiliated with King Saud University whose scholarly profile is situated within biochemistry, genetics and molecular biology. The available research record indicates activity spanning molecular responses, microbiota, probiotics, nanomaterials, cancer biology and physiological stress. The profile reports 105 documents, 1,901 citations and an h-index of 25, providing quantitative indicators of sustained scholarly output and citation impact.

Abstract

This academic recognition profile presents the research record of Ramesa Shafi in biochemistry, genetics and molecular biology. Recent publications address biological activities of plant-derived silver nanoparticles, probiotic and bee-pollen interventions, microbiota in lupus nephritis, adrenomedullin expression in breast cancer and biochemical responses to sodium halide stress. These studies collectively illustrate an interdisciplinary approach to molecular and physiological research.[1]

Keywords

Biochemistry; Genetics; Molecular Biology; Microbiota; Probiotics; Nanoparticles; Cancer Biology; Physiological Stress; Research Excellence.

Introduction

Research in biochemistry and molecular biology increasingly connects cellular mechanisms with environmental, nutritional and disease-related responses. Shafi’s reported publications reflect this multidisciplinary direction, with studies examining molecular pathways and biological responses across experimental and clinical contexts.[2]

Research Profile

The research profile is characterized by work at the intersection of biochemical processes, molecular regulation and biological responses. The reported Scopus metrics—105 documents, 1,901 citations and an h-index of 25—provide measurable indicators of publication activity and scholarly influence.[1]

Research Contributions

  • Investigation of biological activities associated with Ocimum basilicum flower-derived silver nanoparticles.[2]
  • Evaluation of probiotic and bee-pollen supplementation in intestinal tight-junction responses.[3]
  • Analysis of microbiota as a potential therapeutic target in lupus nephritis.[4]
  • Study of adrenomedullin and receptor expression in breast cancer among Saudi patients.[5]

Publications

  • Biological Activities and Host-Response Insights of Ocimum basilicum Flower-Derived Silver Nanoparticles. Inorganics, 2026.
  • Multi-Strain Probiotic and Bee Pollen Supplementation Attenuates CCl4-Induced Altered Intestinal Tight Junctions in Rodents. Current Issues in Molecular Biology, 2026.
  • The Dual Role of Microbiota as a Therapeutic Target in Lupus Nephritis. Turkish Journal of Nephrology, 2025.
  • Expression Patterns of Adrenomedullin and its Receptors in Breast Cancer Among Saudi Patients. International Journal of Pharmacology, 2025.
  • Biochemical and Physiological Responses to Sodium Halide Stress in Mung Beans Sprouts. Fluoride – Quarterly Reports, 2025.

Research Impact

The reported citation count and h-index indicate that the research output has received measurable scholarly attention. The diversity of publication topics also demonstrates relevance across molecular biology, nutrition-related interventions, disease mechanisms and nanobiotechnology.[1]

Award Suitability

Based on the supplied publication record and bibliometric indicators, Shafi presents a profile relevant to consideration for the Best Researcher Award. The combination of sustained publication activity, citation impact and interdisciplinary research themes provides a reasonable scholarly basis for evaluation under research-output and impact criteria.

Conclusion

Ramesa Shafi’s research profile reflects continued engagement with biochemistry, genetics and molecular biology. Recent work covers nanomaterials, microbiota, probiotics, cancer biology and biochemical stress responses, while the reported bibliometric indicators provide additional evidence of an established research record.

References

  1. Elsevier. (n.d.). Scopus author details: Ramesa Shafi, Author ID 57442927600. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57442927600
  2. MDPI. (2026). Biological Activities and Host-Response Insights of Ocimum basilicum Flower-Derived Silver Nanoparticles. Inorganics.
    https://doi.org/10.3390/inorganics14080216
  3. MDPI. (2026). Multi-Strain Probiotic and Bee Pollen Supplementation Attenuates CCl4-Induced Altered Intestinal Tight Junctions in Rodents. Current Issues in Molecular Biology.
    https://doi.org/10.3390/cimb48030310
  4. Turkish Journal of Nephrology. (2025). The Dual Role of Microbiota as a Therapeutic Target in Lupus Nephritis.
    https://doi.org/10.5152/turkjnephrol.2025.25981
  5. International Journal of Pharmacology. (2025). Expression Patterns of Adrenomedullin and its Receptors in Breast Cancer Among Saudi Patients.
    https://doi.org/10.3923/ijp.2025.200.208
  6. Publons / Web of Science. (2025). Biochemical and Physiological Responses to Sodium Halide Stress in Mung Beans Sprouts.
    https://publons.com/wos-op/publon/76884309/

Gaffar Sarwar Zaman | Biochemistry | Excellence in Research

Published on by Academic Excellence

Dr. Gaffar Sarwar Zaman | Biochemistry | Excellence in Research

Dr. Gaffar Sarwar Zaman, King Khalid University, Saudi Arabia

Dr. Gaffar Sarwar Zaman is a distinguished Assistant Professor in the Department of Clinical Laboratory Sciences at King Khalid University, Abha, Saudi Arabia. With a robust academic background, including an MBBS, an MD in Biochemistry, and fellowships in Diabetes and Applied Nutrition, Dr. Zaman has established himself as a leading expert in medical biochemistry and clinical research. His extensive work in biochemical diagnostics and metabolic disorders has been instrumental in advancing medical science. Passionate about research, he has contributed significantly to the fields of cardiovascular biochemistry, metabolic diseases, and clinical nutrition. He has published high-impact scientific papers and actively collaborates with international researchers. Dr. Zaman’s dedication to education, research, and clinical excellence has earned him recognition in the global scientific community. His expertise in applied medical biochemistry continues to influence the advancement of healthcare practices and diagnostic methodologies worldwide.

Professional Profile 

Scopus

Orcid

google Scholar

Summary of Suitability for the “Research for Excellence in Research” Award

Dr. Gaffar Sarwar Zaman is a highly accomplished researcher and academic, making him an excellent candidate for the “Research for Excellence in Research” award. He holds multiple advanced degrees, including an MBBS, MD (Doctor of Medicine in Biochemistry), and specialized fellowships in diabetes and applied nutrition. His educational background is complemented by extensive experience in clinical research and laboratory sciences. Dr. Zaman’s multi-faceted expertise in medicine, biochemistry, clinical research, and nutrition showcases his versatility and commitment to advancing knowledge in these fields.

Dr. Zaman has made significant contributions to the scientific community through his research, with a focus on critical areas such as diabetes, nutrition, and biochemical markers. His published works, including studies on zearalenone detection in agricultural food samples and cardiovascular biomarkers in different environmental settings, highlight his ability to bridge clinical practice with cutting-edge research. His articles, published in reputable journals such as Materials Chemistry and Physics and Cellular and Molecular Biology, are indexed in leading databases like PubMed and Web of Science. This, along with his strong publication record in high-impact journals, underscores his excellence in research.

🎓 Education 

Dr. Gaffar Sarwar Zaman pursued his MBBS from Assam Medical College & Hospital, Dibrugarh University, India, where he acquired a strong foundation in medical sciences, including anatomy, physiology, pathology, and pharmacology. His keen interest in biochemistry led him to earn an MD (Doctor of Medicine) in Biochemistry, with a thesis on “Quantitation of Serum Iron with Assessment of Consequent Anemia during Pregnancy.” Expanding his expertise, he completed a Post Graduate Diploma in Clinical Research (PGDCR) from Symbiosis International University, India, equipping him with skills in clinical research methodology, biostatistics, and data analysis. Furthering his specialization, Dr. Zaman attained a Fellowship in Diabetes (FID) from the Royal Liverpool Academy, UK, and a Fellowship in Applied Nutrition (FIAN) from Medvarsity, Apollo Hospitals, India. These advanced qualifications have enabled him to contribute extensively to clinical diagnostics, metabolic research, and nutritional sciences, enhancing his impact in medical biochemistry.

💼 Professional Experience

Dr. Gaffar Sarwar Zaman has a rich professional career spanning academia, research, and clinical diagnostics. Currently serving as an Assistant Professor in the Department of Clinical Laboratory Sciences at King Khalid University, he plays a crucial role in educating future healthcare professionals and conducting high-impact biochemical research. His expertise extends to biochemical diagnostics, metabolic disorders, and clinical research, where he actively collaborates with international institutions. Before joining King Khalid University, he worked in esteemed medical institutions, refining his skills in clinical biochemistry and laboratory medicine. His work involves biochemical marker analysis, metabolic disease management, and advanced clinical laboratory investigations. His profound knowledge and experience have made him a sought-after expert in biochemical research and medical diagnostics. He is actively involved in scientific publishing, presenting at conferences, and mentoring students in advanced biochemical methodologies, furthering his impact in the global medical community.

🏅 Awards and Recognition

Dr. Gaffar Sarwar Zaman has been widely recognized for his contributions to medical biochemistry and clinical research. His excellence in scientific research has earned him multiple awards and accolades from esteemed organizations. He has received recognition for his pioneering work in cardiovascular biochemistry, metabolic disease diagnostics, and clinical nutrition. Dr. Zaman’s contributions to medical science have been acknowledged in various international conferences and research symposiums. His research publications in high-impact journals have placed him among the leading experts in biochemistry. He has been awarded fellowships, including the Fellowship in Diabetes (FID) and the Fellowship in Applied Nutrition (FIAN), in recognition of his expertise. Additionally, his collaborative research efforts with international institutions have further cemented his reputation as a leading scientist. Dr. Zaman continues to be an influential figure in biochemistry, inspiring young researchers and medical professionals through his dedicated work and groundbreaking research.

🌍 Research Skills On Biochemistry

Dr. Gaffar Sarwar Zaman possesses advanced research skills in medical biochemistry, clinical diagnostics, and metabolic disorders. His expertise lies in biochemical marker analysis, electrochemical biosensors, and nutritional biochemistry. His research focuses on metabolic syndrome, cardiovascular biomarkers, diabetes, and clinical nutrition. Dr. Zaman is proficient in conducting laboratory investigations using advanced biochemical techniques, including spectrophotometry, chromatography, and electrochemical analysis. His research methodology includes data analysis, biostatistics, and clinical trials, ensuring high scientific accuracy and reliability. He has contributed to several peer-reviewed journals and collaborates with international researchers to develop innovative diagnostic techniques. His ability to integrate clinical research with biochemical diagnostics has significantly improved disease detection and management. Dr. Zaman is also skilled in scientific writing, grant proposal development, and mentoring young researchers, making him a key contributor to the field of medical biochemistry and clinical research.

Publication Top Notes

  • Green synthesis of silver nanoparticles by Conocarpus Lancifolius plant extract and their antimicrobial and anticancer activities
    Authors: M Oves, MA Rauf, M Aslam, HA Qari, H Sonbol, I Ahmad, GS Zaman, …
    Saudi Journal of Biological Sciences, 29(1), 460-471
    Year: 2022
  • Pathogenesis of insulin resistance
    Author: GS Zaman
    Cellular Metabolism and Related Disorders, 52
    Year: 2020
  • Ciprofloxacin adsorption using magnetic and ZnO nanoparticles supported activated carbon derived from Azolla filiculoides biomass
    Authors: AA Alameri, RHC Alfilh, SA Awad, GS Zaman, TJ Al-Musawi, MM Joybari, …
    Biomass Conversion and Biorefinery, 14(21), 27001-27014
    Year: 2024
  • A Comparative Antibacterial, Antioxidant, and Antineoplastic Potential of Rauwolfia serpentina (L.) Leaf Extract with Its Biologically Synthesized Gold Nanoparticles
    Authors: MY Alshahrani, Z Rafi, NM Alabdallah, A Shoaib, I Ahmad, M Asiri, …
    Plants, 10(11), 2278
    Year: 2021
  • Synergistic efficacies of thymoquinone and standard antibiotics against multi-drug resistant isolates
    Authors: AA Dera, I Ahmad, P Rajagopalan, M Al Shahrani, A Saif, MY Alshahrani, …
    Saudi Medical Journal, 42(2), 196
    Year: 2021
  • Effects of weight reduction after sleeve gastrectomy on metabolic variables in Saudi obese subjects in Aseer Province of Kingdom of Saudi Arabia
    Authors: MA Bawahab, AS Assiri, WA Maksoud, A Patel, O Kadoumi, GS Zaman, …
    Obesity Surgery, 27, 2005-2014
    Year: 2017
  • Glucose indices, frank and undetected diabetes in relation to hypertension and anthropometry in a South Indian rural population
    Authors: FA Zaman, R Pal, GS Zaman, IA Swati, A Kayyum
    Indian Journal of Public Health, 55(1), 34-37
    Year: 2011
  • Assessment of knowledge, attitude, and practice concerning COVID-19 among undergraduate students of faculty of applied medical sciences at King Khalid University, Abha, Kingdom of Saudi Arabia
    Authors: M Adam, M Gameraddin, M Alelyani, GS Zaman, A Musa, I Ahmad, …
    Advances in Medical Education and Practice, 789-797
    Year: 2021
  • A combined chemical, computational, and in vitro approach identifies SBL-105 as novel DHODH inhibitor in acute myeloid leukemia cells
    Authors: H Kamli, GS Zaman, A Shaikh, AA Mobarki, P Rajagopalan
    Oncology Research, 28(9), 899
    Year: 2022
  • Inhibitory Effect of Nepeta deflersiana on Climax Bacterial Community Isolated from the Oral Plaque of Patients with Periodontal Disease
    Authors: I Ahmad, S Irfan, M Abohashrh, S Wahab, SS Abullais, MA Javali, N Nisar, …
    Molecules, 26(1), 202
    Year: 2021